Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of previously issued balance sheet

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of previously issued balance sheet
Jul. 19, 2021
USD ($)
As Previously Reported [Member]  
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of previously issued balance sheet [Line Items]  
Common stock subject to possible redemption $ 154,073,040
Total common stock subject to possible redemption 154,073,040
Common stock 631
Additional paid-in capital 5,258,926
Accumulated deficit (259,547)
Total stockholders’ equity (deficit) 5,000,010
Adjustments [Member]  
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of previously issued balance sheet [Line Items]  
Common stock subject to possible redemption 7,818,210
Allocation of underwriter’s discounts, offering costs and deferred fees to shares (3,657,956)
Immediate accretion to redemption value 15,991,706
Total common stock subject to possible redemption 20,151,960
Common stock (200)
Additional paid-in capital (5,258,926)
Accumulated deficit (14,892,834)
Total stockholders’ equity (deficit) (20,151,960)
As Revised [Member]  
Basis of Presentation and Summary of Significant Accounting Policies (Details) - Schedule of restatement of previously issued balance sheet [Line Items]  
Common stock subject to possible redemption 161,891,250
Allocation of underwriter’s discounts, offering costs and deferred fees to shares (3,657,956)
Immediate accretion to redemption value 15,991,706
Total common stock subject to possible redemption 174,225,000
Common stock 431
Accumulated deficit (15,152,381)
Total stockholders’ equity (deficit) $ (15,151,950)